Clinical Trials for Areteia Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Areteia Therapeutics

Clinical Trials (5)

NCT06533553
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
PHASE2Active, not recruiting
30 participants
Started: Jul 9, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor23 locations
NCT06388889
Phase III Long-Term Extension Study With Dexpramipexole
PHASE3Enrolling by invitation
1,600 participants
Started: Jun 12, 2024 · Completed: May 31, 2028
1 condition1 sponsor103 locations
NCT05813288
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
PHASE3Recruiting
930 participants
Started: Mar 27, 2023 · Completed: Feb 28, 2027
3 conditions1 sponsor260 locations
NCT05763121
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
PHASE3Recruiting
1,395 participants
Started: Jan 30, 2023 · Completed: May 31, 2027
3 conditions1 sponsor402 locations
NCT05748600
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
PHASE3Active, not recruiting
600 participants
Started: Jan 30, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor335 locations